Join
Live feed
·
PRReleasevia Quantisnow
Capricor Therapeutics Inc. logo

Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

ByQuantisnow·Wall Street's wire, on your screen.
CAPR· Capricor Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CAPR (Capricor Therapeutics Inc.) and more on Quantisnow.